Nova blog
Visit our website
    Nova blog

    The power of synthetic control arms

    Control arms are key to reliably determining whether a new treatment works better than what already exists. The data they generate – from trial patients who receive a placebo, the standard of care (SO ...

    Read more

    NOVA
    Dec 01, 2021
    in-silico insights SCA
    Mechanistic models and AI

    How two distinct, yet complementary approaches could revolutionize R&D Mechanistic modeling and artificial intelligence (AI) are both transforming medicine. AI is being increasingly applied to drug ...

    Read more

    NOVA
    Nov 24, 2021
    in-silico insights disease model AI
    Building trust in in silico modeling

    As technology spreads across healthcare, the trust question becomes more urgent. Should we trust what a digital health app tells us? Can we rely on a diagnosis provided by an algorithm? Can drug devel ...

    Read more

    NOVA
    Aug 04, 2021
    in-silico insights
    A second pillar to bridge the evidence gap

    It’s a red-hot question: how to bridge the gap between available and desired levels of evidence for a drug’s safety and efficacy? [FDA’s approval](https://www.fda.gov/news-events/press-announcements/f ...

    Read more

    NOVA
    Jul 05, 2021
    in-silico insights
    Can equations capture how our bodies work?

    No clinical trial is perfect. The gold-standard randomized controlled trial does a good job of trying to be, but we know its flaws: selection isn’t truly random, conditions often don’t reflect patient ...

    Read more

    NOVA
    Jun 22, 2021
    in-silico insights disease model
    • Visit our website